» Articles » PMID: 23936488

Gene Expression Profiling of Histiocytic Sarcomas in a Canine Model: the Predisposed Flatcoated Retriever Dog

Overview
Journal PLoS One
Date 2013 Aug 13
PMID 23936488
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The determination of altered expression of genes in specific tumor types and their effect upon cellular processes may create insight in tumorigenesis and help to design better treatments. The Flatcoated retriever is a dog breed with an exceptionally high incidence of histiocytic sarcomas. The breed develops two distinct entities of histiocytic neoplasia, a soft tissue form and a visceral form. Gene expression studies of these tumors have value for comparable human diseases such as histiocytic/dendritic cell sarcoma for which knowledge is difficult to accrue due to their rare occurrence. In addition, such studies may help in the search for genetic aberrations underlying the genetic predisposition in this dog breed.

Methods: Microarray analysis and pathway analyses were performed on fresh-frozen tissues obtained from Flatcoated retrievers with localized, soft tissue histiocytic sarcomas (STHS) and disseminated, visceral histiocytic sarcomas (VHS) and on normal canine spleens from various breeds. Expression differences of nine genes were validated with quantitative real-time PCR (qPCR) analyses.

Results: QPCR analyses identified the significantly altered expression of nine genes; PPBP, SpiC, VCAM1, ENPEP, ITGAD (down-regulated), and GTSF1, Col3a1, CD90 and LUM (up-regulated) in the comparison of both the soft tissue and the visceral form with healthy spleen. DAVID pathway analyses revealed 24 pathways that were significantly involved in the development of HS in general, most of which were involved in the DNA repair and replication process.

Conclusions: This study identified altered expression of nine genes not yet implicated in histiocytic sarcoma manifestations in the dog nor in comparable human histiocytic/dendritic sarcomas. Exploration of the downside effect of canine inbreeding strategies for the study of similar sarcomas in humans might also lead to the identification of genes related to these rare malignancies in the human.

Citing Articles

Canine Histiocytic and Hemophagocytic Histiocytic Sarcomas Display and Extensive /SHP2 Mutations and Respond In Vitro to MEK Inhibition by Cobimetinib.

Yang Y, Engleberg A, Kapoor I, Kitagawa K, Hilburger S, Thaiwong-Nebelung T Genes (Basel). 2024; 15(8).

PMID: 39202410 PMC: 11353564. DOI: 10.3390/genes15081050.


Relationship of mRNA Expression of Selected Genes in Peripheral Blood and Synovial Fluid in Cranial Cruciate Ligament Deficient Stifles of Dogs.

Sevcik K, Karaffova V, Hluchy M, Sevcikova M, Sevcikova Z, Ledecky V Animals (Basel). 2022; 12(6).

PMID: 35327152 PMC: 8944536. DOI: 10.3390/ani12060754.


LINC02190 inhibits the embryo-endometrial attachment by decreasing ITGAD expression.

Zhao F, Chen T, Zhao X, Wang Q, Lan Y, Liang Y Reproduction. 2022; 163(2):107-118.

PMID: 35038314 PMC: 8859920. DOI: 10.1530/REP-21-0300.


Mesenchymal to epithelial transition driven by canine distemper virus infection of canine histiocytic sarcoma cells contributes to a reduced cell motility in vitro.

Armando F, Gambini M, Corradi A, Becker K, Marek K, Pfankuche V J Cell Mol Med. 2020; 24(16):9332-9348.

PMID: 32627957 PMC: 7417708. DOI: 10.1111/jcmm.15585.


Identification of two molecular subtypes in canine mast cell tumours through gene expression profiling.

Pulz L, Barra C, Alexandre P, Huete G, Cadrobbi K, Nishiya A PLoS One. 2019; 14(6):e0217343.

PMID: 31216299 PMC: 6583995. DOI: 10.1371/journal.pone.0217343.


References
1.
Fulmer A, Mauldin G . Canine histiocytic neoplasia: an overview. Can Vet J. 2007; 48(10):1041-3, 1046-50. PMC: 1978291. View

2.
Danilenko D, Rossitto P, Van der Vieren M, Le Trong H, McDonough S, Affolter V . A novel canine leukointegrin, alpha d beta 2, is expressed by specific macrophage subpopulations in tissue and a minor CD8+ lymphocyte subpopulation in peripheral blood. J Immunol. 1995; 155(1):35-44. View

3.
Breen M, Modiano J . Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans--man and his best friend share more than companionship. Chromosome Res. 2008; 16(1):145-54. DOI: 10.1007/s10577-007-1212-4. View

4.
Davies F, Dring A, Li C, Rawstron A, Shammas M, OConnor S . Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood. 2003; 102(13):4504-11. DOI: 10.1182/blood-2003-01-0016. View

5.
Paoloni M, Khanna C . Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer. 2008; 8(2):147-56. DOI: 10.1038/nrc2273. View